eEF-2 Phosphorylation Down-Regulates P-Glycoprotein Over-Expression in Rat Brain Microvessel Endothelial Cells. 2015

Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.

OBJECTIVE We investigated whether glutamate, NMDA receptors, and eukaryote elongation factor-2 kinase (eEF-2K)/eEF-2 regulate P-glycoprotein expression, and the effects of the eEF-2K inhibitor NH125 on the expression of P-glycoprotein in rat brain microvessel endothelial cells (RBMECs). METHODS Cortex was obtained from newborn Wistar rat brains. After surface vessels and meninges were removed, the pellet containing microvessels was resuspended and incubated at 37°C in culture medium. Cell viability was assessed by the MTT assay. RBMECs were identified by immunohistochemistry with anti-vWF. P-glycoprotein, phospho-eEF-2, and eEF-2 expression were determined by western blot analysis. Mdr1a gene expression was analyzed by RT-PCR. RESULTS Mdr1a mRNA, P-glycoprotein and phospho-eEF-2 expression increased in L-glutamate stimulated RBMECs. P-glycoprotein and phospho-eEF-2 expression were down-regulated after NH125 treatment in L-glutamate stimulated RBMECs. CONCLUSIONS eEF-2K/eEF-2 should have played an important role in the regulation of P-glycoprotein expression in RBMECs. eEF-2K inhibitor NH125 could serve as an efficacious anti-multidrug resistant agent.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D054736 Elongation Factor 2 Kinase A monomeric calcium-calmodulin-dependent protein kinase subtype that specifically phosphorylates PEPTIDE ELONGATION FACTOR 2. The enzyme lacks a phosphorylatable activation domain that can respond to CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE, however it is regulated by phosphorylation by PROTEIN KINASE A and through intramolecular autophosphorylation. Calcium-Calmodulin-Dependent Protein Kinase Type 3,Calmodulin-Dependent Protein Kinase III,CAM Kinase III,Cam PK III,E-2 Kinase,EF-2 Kinase,Eukaryotic Elongation Factor-2 Kinase,Protein Kinase CPK3,eEF-2-Specific Ca and Calmodulin-Dependent Protein Kinase III,Calcium Calmodulin Dependent Protein Kinase Type 3,Calmodulin Dependent Protein Kinase III,E 2 Kinase,EF 2 Kinase,Eukaryotic Elongation Factor 2 Kinase,Kinase CPK3, Protein,Kinase, EF-2,eEF 2 Specific Ca and Calmodulin Dependent Protein Kinase III

Related Publications

Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
October 2013, European journal of pharmacology,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
July 2004, Life sciences,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
August 1998, Journal of neurochemistry,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
April 2006, Acta pharmacologica Sinica,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
October 2013, The Journal of pharmacy and pharmacology,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
September 2006, Journal of neurochemistry,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
July 2007, The Journal of pharmacy and pharmacology,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
December 2004, Die Pharmazie,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
September 2012, Microvascular research,
Xing Hua Tang, and Xun Yi Wu, and Lan Xu, and You Xin Fang, and Ping Wang, and Guo Xing Zhu, and Zhen Hong
September 2013, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!